Short-term dexamethasone treatment for symptomatic slit ventricle syndrome

Childs Nerv Syst. 2005 Nov;21(11):981-4. doi: 10.1007/s00381-004-1132-y. Epub 2005 Jun 3.

Abstract

Objective: The objective was to report our positive experience of using dexamethasone to treat 13 patients with symptomatic slit ventricle syndrome (SVS).

Methods: Thirteen SVS patients who received dexamethasone during acute episodes were studied. The etiology for hydrocephalus was prematurity and intraventricular hemorrhage in 9 patients and neonatal meningitis, chorioamnionitis, Dandy-Walker variant, and congenital in 1 case each. The shunt was inserted at 1.8+/-1.0 months of age and SVS was diagnosed at 4.9+/-3.2 years of age.

Results: All patients reported relief and shorter duration of symptoms with dexamethasone. Surgical intervention was decided upon and carried out within 11+/-8 months of SVS diagnosis in 9 out of 13 patients. The other 4 are being monitored and continue to receive dexamethasone when needed.

Conclusions: Dexamethasone appears to be a useful treatment in acutely increased intracranial pressure caused by SVS. It can provide temporary relief during the decision-making process of whether and when to perform surgery.

MeSH terms

  • Acute Disease
  • Cerebral Ventricles / pathology*
  • Child
  • Child, Preschool
  • Dexamethasone / administration & dosage*
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Humans
  • Hydrocephalus / drug therapy*
  • Hydrocephalus / etiology
  • Infant
  • Infant, Newborn
  • Infant, Premature, Diseases / drug therapy
  • Infant, Premature, Diseases / etiology
  • Male
  • Syndrome
  • Ventriculoperitoneal Shunt

Substances

  • Dexamethasone